Hologic Stock (HOLX) Climbs as Blackstone and TPG Renew Take-Private Bid
Medical device Maker Hologic's shares surged Wednesday as takeover talks resurfaced. Blackstone and TPG have revived interest in acquiring the women's health-focused company, reportedly motivated by its depressed valuation and CEO compensation structure. The $16 billion proposal—including $2.5 billion in assumed debt—comes five months after Hologic rejected a similar offer.
Negotiations remain fluid as the firm pursues revenue growth. CEO Steve MacMillan stands to gain over $40 million in stock and cash if the deal materializes. The renewed bid underscores private equity's appetite for healthcare assets despite volatile markets.